Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients.
about
The impact of comorbidity on cancer and its treatmentImpact of Age and Comorbidity on Cervical and Breast Cancer Literacy of African Americans, Latina, and Arab WomenNativity disparities in late-stage diagnosis and cause-specific survival among Hispanic women with invasive cervical cancer: an analysis of Surveillance, Epidemiology, and End Results dataThe California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survivalBreast cancer molecular subtypes of Uygur and Han in Xinjiang of China.Medical comorbidities predict mortality in women with a history of early stage breast cancer.Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance)Long-term prognostic role of functional limitations among women with breast cancerA retrospective cohort study of patients with stomach and liver cancers: the impact of comorbidity and ethnicity on cancer care and outcomesObesity is associated with breast cancer in African-American women but not Hispanic women in South Los AngelesHealth Behaviors of Breast Cancer Survivors with Hypertension: A Propensity Analysis of KNHANES III-V (2005-2012).Lifestyle interventions for cardiovascular risk reduction in women with breast cancer.Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC)Racial differences in the use of adjuvant chemotherapy for breast cancer in a large urban integrated health systemThe prevention of cardiovascular disease in cancer survivors.Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women With Newly Diagnosed Breast CancerPrognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE studyComorbidities and endometrial cancer survival in Hispanics and non-Hispanic whites.Individual and neighborhood socioeconomic status and healthcare resources in relation to black-white breast cancer survival disparitiesCorrelates of quality of life among African American and white cancer survivors.Comorbidities and breast cancer survival: a report from the Shanghai Breast Cancer Survival Study.The Effect of Patient and Contextual Characteristics on Racial/Ethnic Disparity in Breast Cancer Mortality.Biomarkers of the metabolic syndrome and breast cancer prognosis.Influence of obesity on breast cancer receptor status and prognosis.Antihypertensive medication adherence in cancer survivors and its affecting factors: results of a Korean population-based study.Racial differences in the effects of comorbidity on breast cancer-specific survival.Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer.Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis.Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities.The effect of delays in treatment for breast cancer metastasis on survival.Factors associated with mortality after breast cancer metastasis.Validation of self-reported comorbidity status of breast cancer patients with medical records: the California Breast Cancer Survivorship Consortium (CBCSC).Racial and ethnic disparities in cost-related medication non-adherence among cancer survivors.Obesity and angiolymphatic invasion in primary breast cancer.Comorbidity burden and guideline-concordant care for breast cancer.Physical activity in Black breast cancer survivors: implications for quality of life and mood at baseline and 6-month follow-up.Predicting hypertension among Korean cancer survivors: A nationwide population-based study.Clinical study on the prevalence and comparative analysis of metabolic syndrome and its components among Chinese breast cancer women and control population.Comparison of hypertension management between cancer survivors and the general public.Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer.
P2860
Q26764935-3F7528A5-F1C6-4904-AFBE-E83813DB8F86Q28082544-ECB74A07-698C-49FF-9F72-11F5E7EDB18EQ30660801-D9498CE4-E2E9-4A78-98C0-87DE7DD90F23Q33716455-17884903-7A28-4DBB-9321-EE54BF843124Q33756351-BB8D55AE-3E7F-4D93-8CC9-1711A923F5FFQ33956785-766754E5-67F1-49C2-BBF4-7ADBAAEA7178Q34168190-394F3365-636C-4248-8B15-76FC8D4D3816Q34176406-E89EA6E6-A987-4288-9BB2-2A334DA717F5Q34517306-4B52D851-F81E-48C6-AE39-B74839319507Q35115801-250AAB91-BE99-426C-8E8B-59316220004CQ35610862-3F428758-5B1A-4C71-A5D8-F8D05EFB326FQ35878469-2AEA0B2B-834E-4A39-8519-EE8538F186B2Q35911581-08506BE8-E4F4-4DE6-818F-A208ECCC2930Q35997771-8A0C99C2-BD1E-4322-B16D-B9702577C9D9Q36061056-608C2542-FA11-4757-9898-B931CAA21104Q36173493-ECDCB82C-1DAE-4A87-97E6-11BBCD09A439Q36315921-875D60F7-5173-4AF9-B3F2-D7810E869A96Q36487462-5448B41E-0914-4F6C-8F05-84FD15B3F325Q36663508-5302D2E9-5306-41A0-A1EC-E19E03A2D09AQ36747860-FD42C45E-4669-466C-BA5F-066DC18A18DFQ37017213-8921FAC7-AE54-48DC-8950-988E94DFC671Q37059764-136E300F-5803-41B3-8562-42F2485BD04AQ37328339-82C8EF34-0DDF-40A5-8C94-95675CCCA48DQ37577918-552D2B0F-F939-4534-9305-C7D88541BBFDQ37675995-5589049E-EF7B-4A3F-BEA4-2E01C48B4DB9Q38712771-12206EC8-456D-4F9E-8381-E5BD5E4EFD37Q39689209-6F7BA096-A4CA-492F-9FC2-CA3A4830D529Q39901144-D6D1F964-464D-4A05-8B3A-41A5C3D72F5EQ39972544-B581DD02-4F0F-44A5-8D19-809FEF748DE9Q39990429-37132E76-B3E0-4289-BBAD-BAF3C45857F1Q40004897-2AE25A02-593B-4E34-9D76-50853D50FC83Q40075923-8D30BF83-E221-4BAE-AA6A-0AA601A6762CQ40259785-CDE10F07-DCCB-4D18-A631-42803FA3D9C6Q43245975-9D98F5A1-027E-4388-98A8-7DECB6778A36Q44103169-EC920FC8-4DC0-4B5F-B881-02B431149728Q47577700-81462758-0C0A-4DE6-B328-A02B28701FA0Q48245348-A2D9F198-9E1B-413B-BBA7-E4129E5825E5Q50292353-5392393F-36E0-4D27-94AA-B9E5AF3F0E48Q53379099-1E2B4547-C55A-41FC-A7C6-E8E0A013BD46Q53709840-BA22F684-D30A-4A76-8626-28287132C331
P2860
Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Hypertension is an independent ...... white breast cancer patients.
@en
Hypertension is an independent ...... white breast cancer patients.
@nl
type
label
Hypertension is an independent ...... white breast cancer patients.
@en
Hypertension is an independent ...... white breast cancer patients.
@nl
prefLabel
Hypertension is an independent ...... white breast cancer patients.
@en
Hypertension is an independent ...... white breast cancer patients.
@nl
P2093
P2860
P356
P1476
Hypertension is an independent ...... d white breast cancer patients
@en
P2093
Dan H Moore
Dee W West
Dejana Braithwaite
Elissa M Ozanne
Jeff Belkora
Laura Esserman
Michael Liebman
Robert A Hiatt
William A Satariano
P2860
P304
P356
10.1002/IJC.24054
P577
2009-03-01T00:00:00Z